Evidence map›Paper›PMID 42404231›Full record

ArticleFrontiers in oncology2026

Explainable incremental-value analysis of apparent diffusion coefficient and arterial spin labeling radiomics for ATRX status prediction in glioblastoma.

Rafail C Christodoulou, Revati Natu, Georgios Vamvouras, Platon S Papageorgiou, Evros Vassiliou, Elena E Solomou, Sokratis G Papageorgiou, Michalis F Georgiou

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rafail C ChristodoulouDivision of Neuroimaging and Neurointervention, Department of Radiology, Stanford University, Stanford, CA, United States.
Revati NatuDepartment of Information Technology, K. J. Somaiya School of Engineering, Somaiya Vidyavihar University, Mumbai, India.
Georgios VamvourasDepartment of Electrical and Computer Engineering, National Technical University of Athens NTUA, Athens, Greece.
Platon S PapageorgiouDepartment of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Evros VassiliouDepartment of Biological Sciences, Kean University, Union, NJ, United States.
Elena E SolomouInternal Medicine-Hematology, University of Patras Medical School, Rion, Greece.
Sokratis G Papageorgiou1st Department of Neurology, Medical School, National and Kapodistrian University of Athens, Eginition Hospital, Athens, Greece.
Michalis F GeorgiouDepartment of Radiology, University of Miami, Miami, FL, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Alpha-thalassemia/mental retardation syndrome X-linked (ATRX) mutation is an uncommon but biologically relevant molecular feature in glioblastoma (GBM), linked to tumor heterogeneity, DNA damage response pathways, and treatment-relevant biology. Noninvasive prediction of ATRX status remains challenging, and the incremental value of physiologic MRI beyond structural imaging is unclear. Methods: We analyzed 106 patients with GBM with available ATRX status and complete multiparametric MRI. Four radiomics models were compared. Model 1 used structural MRI features from contrast-enhanced T1-weighted, T2-weighted, and FLAIR images, along with age and sex. Model 1A additionally incorporated ADC and ASL-CBF radiomic features. Models 1B and 1C served as ablation models isolating the individual contribution of ADC and ASL-CBF, respectively. Six machine-learning classifiers were evaluated using stratified cross-validation, class-imbalance-aware metrics, bootstrapped confidence intervals, paired DeLong testing, and SHAP explainability. Results: The best structural model achieved an ROC-AUC of 0.721, a PR-AUC of 0.322, and a sensitivity of 0.737. Model 1A demonstrated statistically significant improvements, achieving an ROC-AUC of 0.753, a PR-AUC of 0.364, and a sensitivity of 0.947. Across classifiers, ADC and ASL improved discrimination in five of six classifiers (DeLong, p<0.05). SHAP analysis showed that age remained the dominant predictor, while ASL- and ADC-derived texture features contributed meaningful physiologic information. Discussion: ADC and ASL-CBF radiomics provide a modest but statistically significant incremental value for ATRX prediction in GBM. These findings support further validation of functional MRI sequences as a complementary radiogenomic marker.

Indexed as

apparent diffusion coefficientarterial spin labelingATRXexplainabilityglioblastomamachine learningMRIradiomics

Identifiers

PMID42404231
PMCPMC13327862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.